Mesoblast Limited (LWB) - Total Liabilities

Latest as of December 2025: €207.62 Million EUR ≈ $242.73 Million USD

Based on the latest financial reports, Mesoblast Limited (LWB) has total liabilities worth €207.62 Million EUR (≈ $242.73 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Mesoblast Limited's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Mesoblast Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Mesoblast Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see LWB total assets.

Mesoblast Limited Competitors by Total Liabilities

The table below lists competitors of Mesoblast Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Fengzhushou Co. Ltd. A SHE:301382	China	CN¥1.75 Billion
Guangzhou Zhiguang Electric Co Ltd SHE:002169	China	CN¥7.34 Billion
Kinnevik Investment AB ser. B ST:KINV-B	Sweden	Skr2.22 Billion
Southern Publishing&Media Co SHG:601900	China	CN¥8.54 Billion
Hangzhou Kelin Electric Co. Ltd. A SHG:688611	China	CN¥208.95 Million
Permian Basin Royalty Trust NYSE:PBT	USA	$2.25 Million
SL Corp KO:005850	Korea	₩1.35 Trillion
Kemper Corporation NYSE:KMPR	USA	$9.75 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Mesoblast Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Mesoblast Limited balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.27	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Mesoblast Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Mesoblast Limited (2014–2025)

The table below shows the annual total liabilities of Mesoblast Limited from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	€187.24 Million ≈ $218.90 Million	-0.82%
2024-06-30	€188.80 Million ≈ $220.72 Million	+12.66%
2023-06-30	€167.58 Million ≈ $195.92 Million	+1.50%
2022-06-30	€165.10 Million ≈ $193.02 Million	+1.09%
2021-06-30	€163.32 Million ≈ $190.94 Million	-11.37%
2020-06-30	€184.28 Million ≈ $215.44 Million	+7.72%
2019-06-30	€171.06 Million ≈ $199.99 Million	+16.82%
2018-06-30	€146.44 Million ≈ $171.20 Million	+5.41%
2017-06-30	€138.92 Million ≈ $162.41 Million	-10.87%
2016-06-30	€155.86 Million ≈ $182.21 Million	-50.33%
2015-06-30	€313.78 Million ≈ $366.84 Million	+1.56%
2014-06-30	€308.95 Million ≈ $361.20 Million	--

About Mesoblast Limited

F:LWB Germany Biotechnology

Market Cap

$1.88 Billion

€1.61 Billion EUR

Market Cap Rank

#7121 Global

#1002 in Germany

Share Price

€1.25

Change (1 day)

+0.40%

52-Week Range

€1.09 - €1.71

All Time High

€3.48